Index to Posts on Pharming [New entries for 9/22/08 Rhucin update and CEO change.] Rhucin: <a href='read_msg.asp?message_id=30791896'>#msg-30791896</a> Regulatory update on Rhucin (9/22/08) <a href='read_msg.asp?message_id=30035067'>#msg-30035067</a> Phase-3 Rhucin data (US) <a href='read_msg.asp?message_id=22482530'>#msg-22482530</a> Pharming seeks US Rhucin partner <a href='read_msg.asp?message_id=22208171'>#msg-22208171</a> Phase-3 Rhucin data (Europe) <a href='read_msg.asp?message_id=27808107'>#msg-27808107</a> EMEA rejects Rhucin re-examination <a href='read_msg.asp?message_id=30621194'>#msg-30621194</a> Rhucin open-label extension studies Intellectual property: <a href='read_msg.asp?message_id=30659059'>#msg-30659059</a> Musings on a GTC-Pharming merger <a href='read_msg.asp?message_id=18949245'>#msg-18949245</a> IP cross-license with GTC <a href='read_msg.asp?message_id=27220955'>#msg-27220955</a> Pharming licenses cattle IP from ACTC Financial and general: <a href='read_msg.asp?message_id=32444826'>#msg-32444826</a> New CEO named <a href='read_msg.asp?message_id=30791875'>#msg-30791875</a> 1H08 financial results <a href='read_msg.asp?message_id=28546713'>#msg-28546713</a> Update from 2008 annual meeting <a href='read_msg.asp?message_id=28738755'>#msg-28738755</a> New program in “aging”